Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:40:53.379Z.
Calculation as of: 2026-10-06T16:40:53.379Z.
Quote observation: 2026-10-06T16:18:47.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 34d3acea87fa6ce77646ae7da5683b25b27ba1f8f215b5f9e1848d21fed1287f
EARNINGS YIELD
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aytu BioPharma, Inc. (AYTU) | $22.31M | N/A | N/A | N/A | N/A |
| LeonaBio, Inc. (LONA)vs › | $22.24M | N/A | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $21.68M | N/A | N/A | N/A | N/A |
| Rein Therapeutics Inc. (RNTX)vs › | $22.97M | N/A | N/A | N/A | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.80M | N/A | N/A | N/A | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.38M | N/A | 0.04% | 0.04% | 0.04% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.70M | N/A | 0.06% | 0.06% | 0.06% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.72M | N/A | N/A | N/A | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.51M | N/A | N/A | N/A | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $25.30M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute